ArticleJournal of clinical medicine2022

Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis.

Naohiko Kinoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.